ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1175

Thirty Day Readmission Rates for Patients Diagnosed with Systemic Lupus Erythematosus: Analysis at a Tertiary Care Center

Sadiq Ali1, Stephen Mullis2, Nkechi Emejuaiwe1 and Dennis Ang1, 1Section on Rheumatology and Immunology, Wake Forest University, Winston Salem, NC, 2Department of Internal Medicine, Wake Forest University, Winston Salem, NC

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Lupus, population studies and quality improvement

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Epidemiology and Public Health - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic illness that has been associated with high hospital readmission rates. Based on a recently published (Arth Rheumatol (2014) 66:2828) electronic database analysis of Medicare/Medicaid hospital discharges, 16.5% of patients with the ICD-9-CM code 710.0 for SLE were readmitted to any hospital within thirty days. We propose a retrospective, observational study to assess the rate of and predictive factors influencing a thirty-day hospital readmission for adult patients with SLE.

Methods: All index admissions, defined as hospital admissions from adult patients (≥ 18 years of age) who had a primary or secondary ICD-9-CM diagnosis of 710.0 from October 1, 2012 to December 30, 2014, were discovered through data mining. Individual electronic patient charts from these admissions were manually reviewed to determine if the patient fulfilled the 1997 ACR revised criteria for SLE. Hospitalizations were excluded if they were scheduled admissions, resulted in a discharge to acute rehab, maternity related or resulted in death. The remaining hospitalizations were analyzed to determine if they resulted in a thirty-day readmission, using the same methods of determining thirty-day readmission counts performed in the benchmark study of readmission rates in Medicare’s fee-for-service program.

Results: 1003 index admissions (obtained from 433 unique patients) met our inclusion criteria. Only 196 of the 433 patients (45.3%) fulfilled criteria for SLE. The other 237 patients (54.7%) did not meet criteria: 185 patients had an inappropriate diagnosis of SLE (i.e., chart review contained sufficient data to support an alternate diagnosis), 34 patients had limited cutaneous lupus, and 18 patients had insufficient data to either confirm or refute a diagnosis of SLE. After application of exclusion criteria, 88 patients remained, accounting for 293 admissions, broken down into 221 index admissions (75.4%) and 72 thirty-day readmissions (24.6%). Of the 88 patients, 33 patients (37.5%) had ≥1 thirty-day readmission. Demographic data including age (p=0.92), gender (p=0.75), race/ethnicity (p=0.82), median household income by zip code (p=0.078) and primary expected payer (p=0.322) was compared between the groups. Of those with ≥1 thirty-day readmission, 11 were deceased (33.3%) compared to 3 deceased in those without a thirty-day readmission (5.5%) (p=0.0005).

Conclusion: We discovered a 37.5% rate of thirty-day readmission in patients meeting the 1997 revised criteria for the diagnosis of SLE. Among patients with ≥1 thirty-day readmission, a lower mean household income per zip code (p=0.078) was observed, approaching significance. All cause mortality was significantly increased in patients with SLE and ≥1 thirty-day readmission (p=0.0005). Additionally, our study revealed a 54.7% rate of miscoding of hospital records for adult patients with a primary or secondary diagnosis of SLE designated by the ICD-9-CM code 710.0, questioning the validity of using ICD-9-CM codes to identify patients with SLE.


Disclosure: S. Ali, None; S. Mullis, None; N. Emejuaiwe, None; D. Ang, None.

To cite this abstract in AMA style:

Ali S, Mullis S, Emejuaiwe N, Ang D. Thirty Day Readmission Rates for Patients Diagnosed with Systemic Lupus Erythematosus: Analysis at a Tertiary Care Center [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/thirty-day-readmission-rates-for-patients-diagnosed-with-systemic-lupus-erythematosus-analysis-at-a-tertiary-care-center/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/thirty-day-readmission-rates-for-patients-diagnosed-with-systemic-lupus-erythematosus-analysis-at-a-tertiary-care-center/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology